Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques

doi:10.1084/jem.164.4.1013

This Article

	Full Text (PDF, 1247K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Gottlieb, A. B.
	Articles by Carter, D. M.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Gottlieb, A. B.
	Articles by Carter, D. M.


Social Bookmarking

	What's this?

ARTICLES

Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques

AB Gottlieb, B Lifshitz, SM Fu, L Staiano-Coico, CY Wang and DM Carter

Immunoperoxidase staining of skin sections and immunofluorescence analysis of keratinocyte suspensions obtained from suction blisters of psoriatic plaques were performed using an mAb, Josh 524.4.1, and Fab'2 fragments of a rabbit antiserum, both of which are directed against nonpolymorphic determinants of HLA-DR molecules. HLA-DR+ keratinocytes were present in plaques, but not normal-appearing skin, from a significant portion of patients with active psoriasis. Double-labelling immunofluorescence experiments with either the monoclonal or polyclonal anti-HLA-DR antibody, in conjunction with the mAb OKT6, which identifies DR+ Langerhans cells, demonstrated that HLA-DR molecules were present on OKT6- keratinocytes. The dermal infiltrate of psoriatic plaques contained T cells expressing the activation antigens, IL-2 receptor (Tac) and HLA-DR, as well as macrophages and OKT6+ cells. There was little difference in the characteristics of the dermal infiltrate between the lesions with or without HLA-DR+ keratinocytes. OKT6+ presumptive Langerhans cells were also found in the dermal infiltrates of patients with lichen planus, contact dermatitis, spongiotic dermatitis, erythema multiforme, basal and squamous cell carcinoma. Studies of keratinocyte suspensions showed that 7-84% of keratinocytes were HLA-DR+. Flow cytometry experiments showed that keratinocytes at all stages of differentiation were HLA-DR+. However, the stem cell-enriched population contained the highest proportion of HLA-DR+ cells. HLA-DR expression by keratinocytes correlated with disease activity. The expression was reversible with successful medical therapy. HLA-DR+ keratinocytes may activate T cells directly or may present an as yet unknown antigen to T cells. These studies provide further support for the hypothesis that immunological mechanisms play an important role in the pathogenesis of psoriasis.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Gottlieb, A. B., Chamian, F., Masud, S., Cardinale, I., Abello, M. V., Lowes, M. A., Chen, F., Magliocco, M., Krueger, J. G. (2005). TNF Inhibition Rapidly Down-Regulates Multiple Proinflammatory Pathways in Psoriasis Plaques. J. Immunol. 175: 2721-2729 [Abstract] [Full Text]
Mortensen, D. L., Walicke, P. A., Wang, X., Kwon, P., Kuebler, P., Gottlieb, A. B., Krueger, J. G., Leonardi, C., Miller, B., Joshi, A. (2005). Pharmacokinetics and Pharmacodynamics of Multiple Weekly Subcutaneous Efalizumab Doses in Patients With Plaque Psoriasis. J Clin Pharmacol 45: 286-298 [Abstract] [Full Text]
Gottlieb, A. B., Krueger, J. G., Wittkowski, K., Dedrick, R., Walicke, P. A., Garovoy, M. (2002). Psoriasis as a Model for T-Cell-Mediated Disease: Immunobiologic and Clinical Effects of Treatment With Multiple Doses of Efalizumab, an Anti-CD11a Antibody. Arch Dermatol 138: 591-600 [Abstract] [Full Text]
Murphy, F. P., Coven, T. R., Burack, L. H., Gilleaudeau, P., Cardinale, I., Auerbach, R., Krueger, J. G. (1999). Clinical Clearing of Psoriasis by 6-Thioguanine Correlates With Cutaneous T-Cell Depletion via Apoptosis: Evidence for Selective Effects on Activated T Lymphocytes. Arch Dermatol 135: 1495-1502 [Abstract] [Full Text]
(1997). Immunopathogenesis of Psoriasis: The Road From Bench to Bedside is a 2-Way Street. Arch Dermatol 133: 781-782 [Abstract]
Chang, E. Y., Hammerberg, C., Fisher, G., Baadsgaard, O., Ellis, C. N., Voorhees, J. J., Cooper, K. D. (1992). T-Cell Activation Is Potentiated by Cytokines Released by Lesional Psoriatic, but Not Normal, Epidermis. Arch Dermatol 128: 1479-1485 [Abstract]
Kasteler, J. S., Petersen, M. J., Vance, J. E., Zone, J. J. (1992). Circulating Activated T Lymphocytes in Autoeczematization. Arch Dermatol 128: 795-798 [Abstract]
Khandke, L., Krane, J. F., Ashinoff, R., Staiano-Coico, L., Granelli-Piperno, A., Luster, A. D., Carter, D. M., Krueger, J. G., Gottlieb, A. B. (1991). Cyclosporine in Psoriasis Treatment: Inhibition of Keratinocyte Cell-Cycle Progression in G1 Independent of Effects on Transforming Growth Factor {alpha}/Epidermal Growth Factor Receptor Pathways. Arch Dermatol 127: 1172-1179 [Abstract]
Smoller, B. R., McNutt, N. S., Gray, M. H., Krueger, J., Hsu, A., Gottlieb, A. B. (1990). Detection of the Interferon-gamma-Induced Protein 10 in Psoriasiform Dermatitis of Acquired Immunodeficiency Syndrome. Arch Dermatol 126: 1457-1461 [Abstract]
Gottlieb, A. B., Krueger, J. G. (1990). HLA Region Genes and Immune Activation in the Pathogenesis of Psoriasis. Arch Dermatol 126: 1083-1086 [Abstract]
Fierlbeck, G., Rassner, G., Muller, C. (1990). Psoriasis Induced at the Injection Site of Recombinant Interferon Gamma: Results of Immunohistologic Investigations. Arch Dermatol 126: 351-355 [Abstract]